Shield Therapeutics plc (STX.L)

GBp 2.35

(-11.32%)

Operating Expenses Summary of Shield Therapeutics plc

Shield Therapeutics plc's latest annual operating expenses in 2023 was 35.35 Million GBP , up 12.38% from previous year.
Shield Therapeutics plc's latest quarterly operating expenses in 2024 Q2 was 15.47 Million GBP , down 0.0% from previous quarter.
Shield Therapeutics plc reported a annual operating expenses of 27.7 Million GBP in annual operating expenses 2022, up 35.2% from previous year.
Shield Therapeutics plc reported a annual operating expenses of 20.49 Million GBP in annual operating expenses 2021, up 83.17% from previous year.
Shield Therapeutics plc reported a quarterly operating expenses of 16.84 Million GBP for 2023 Q4, down 0.0% from previous quarter.
Shield Therapeutics plc reported a quarterly operating expenses of 14.26 Million GBP for 2023 Q2, down 0.0% from previous quarter.

Annual Operating Expenses Chart of Shield Therapeutics plc (2023 - 2014)

Historical Annual Operating Expenses of Shield Therapeutics plc (2023 - 2014)

Year	Operating Expenses	Operating Expenses Growth
2023	35.35 Million GBP	12.38%
2022	27.7 Million GBP	35.2%
2021	20.49 Million GBP	83.17%
2020	11.18 Million GBP	20.69%
2019	9.26 Million GBP	-44.62%
2018	16.73 Million GBP	-21.91%
2017	21.43 Million GBP	69.24%
2016	12.66 Million GBP	96.83%
2015	6.43 Million GBP	89.74%
2014	3.39 Million GBP	0.0%

Year	Operating Expenses	Operating Expenses Growth
2024 Q2	15.47 Million GBP	0.0%
2023 Q4	16.84 Million GBP	0.0%
2023 Q2	14.26 Million GBP	0.0%
2023 FY	31.13 Million GBP	12.38%
2022 Q2	11.78 Million GBP	0.0%
2022 FY	27.7 Million GBP	35.2%
2022 Q4	14.25 Million GBP	0.0%
2021 Q2	6.42 Million GBP	0.0%
2021 Q4	12.98 Million GBP	0.0%
2021 FY	20.49 Million GBP	83.17%
2020 Q4	4.24 Million GBP	0.0%
2020 Q2	4.23 Million GBP	0.0%
2020 FY	11.18 Million GBP	20.69%
2019 FY	9.26 Million GBP	-44.62%
2019 Q2	3.3 Million GBP	0.0%
2018 Q4	7.09 Million GBP	0.0%
2018 FY	16.73 Million GBP	-21.91%
2018 Q2	- GBP	0.0%
2017 FY	21.43 Million GBP	69.24%
2017 Q2	- GBP	0.0%
2017 Q4	- GBP	0.0%
2016 Q4	- GBP	0.0%
2016 FY	12.66 Million GBP	96.83%
2016 Q2	- GBP	0.0%
2015 FY	6.43 Million GBP	89.74%
2014 FY	3.39 Million GBP	0.0%

Peer Operating Expenses Comparison of Shield Therapeutics plc

Name	Operating Expenses	Operating Expenses Difference